Nantkwest (NK) Stock: Climbing On First-In-Human Trial Results

Nov 08 15:11 2018 Print This Article

Nantkwest Inc (NASDAQ: NK) is flying early on in the trading session this morning, and for good reason. The company released data from the first 300 doses in the first in-human trial of CD16. As you could imagine, the data was positive, exciting investors and sending the stock on a run for the top. Today, we’ll talk about:

The results;

what we’re seeing from NK stock as a result; and

what we’ll be watching for ahead.

NK Announces Clinical Results

As mentioned above, Nantkwest is having a great start to the trading session this morning after releasing clinical data. The data came from the first in human trial of CD16 targeted therapy.

During the trial, the company is assessing CD16 in 30 patients with advanced metastatic cancer refractory to multiple therapies. In the release, NK said that the first 300 doses among 30 patients came with zero incidence of Cytokine Release Syndrome. Also, all patients received the NK Cell Infusion in combination with a novel cancer memory vaccine as outpatients. None of these patients had immune-related adverse events.

Read More

About Article Author

CNA Finance Blog

CNA Finance provides the latest news on catalyst, notable movements, and alpha opportunities in the market. They're a leading finance and investing website that offers content from contributors around the world. CNA focuses heavily on stock market commentary, market analysis, and investing tips.

Related Items

Week Ahead: Nifty has multiple overhead resistances to deal with in this short week

The Indian Equity Markets spent the entire week on expected lines. The previous week was expected to be turbulent, and the zone of 10600-10750 was set to pose stiff resistance to the Markets and on these analyzed lines, the NIFTY continued to remain volatile all throughout the week. The benchmark I ...

You Really CAN Make Money in a Rough Market Environment

The quarter beginning 10-1-18 has been challenging for a lot of traders. The NASDAQ has lost almost 10% while the S&P has lost 6%, both well off the quarter's low. Volatility has reigned with the VIX at elevated levels for most of the quarter. It has been challenging for us at EarningsBeats as well ...

DP Weekly Wrap: Does SPY Have Bullish Reverse H&S? Gold Sentiment Is Looking Contrarian

A lot of people are seeing a reverse head and shoulders pattern developing, and it is really not hard to spot. From Friday's close, it will take a rally of a little less than 3% for price to reach the neckline. Add another 4.5% and new, all-time highs will be made. Some indicators favoring a positi ...

Schedule for Week of November 18, 2018

The key economic reports this week are October Housing Starts and Existing Home Sales.Happy Thanksgiving!----- Monday, Nov 19th ----- 10:00 AM: The November NAHB homebuilder survey. The consensus is for a reading of  68, unchanged from 68. Any number above 50 indicates that more builders view sales ...

Resilient housing joins the machine learning revolution

Machine learning algorithms are excellent at answering “yes” or “no” questions. For example, they can scan huge datasets and correctly tell us: Does this credit card transaction look fraudulent? Is there a cat in this photo? But it’s not only the simple questions – they can also tackle ...

Dollar Lower Ahead of Crucial Week for Brexit and Italian Budget

The US dollar is weaker across the board on Friday. The comments from U.S. Federal Reserve Vice-Chair Richard Clarida on interest rates nearing a neutral rate were dollar negative. Rising optimism about the US-China trade disagreement also depreciated the greenback as investors exited the safe have ...

Burning bright or burned out? The outlook for coal and natural gas markets

This blog is the third in a series of ten blogs on commodity market developments, elaborating on themes discussed in the latest edition of the World Bank’s Commodity Markets Outlook. Earlier blogs can be found here.  Recent developments and outlook: coal Coal prices rose 12 percent in the third ...

November 16, 2018

The TXPR Index hit a new 52-week low today, touching 667.15, well below the prior low (set on October 30) of 669.90. There have now been seven straight days of losses, during which the price index has gone down 2.73%. CPD closed at 13.38, its low for the day, just a penny above its 52-week low set ...